Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03823313 · ClinicalTrials.gov registry record · NA

Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention

A NA study of Advanced Cancer and Metastatic Cancer, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT03823313 is a NA study of Advanced Cancer and Metastatic Cancer that has completed, run by Indiana University. The registered enrollment target is 42 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03823313, a NA study of Advanced Cancer and Metastatic Cancer, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purpose, relationships, transcendence and peace, self-worth and identity. Participants will be asked to complete questionnaires and participate in 4 sessions with research chaplains.

Interventions

  • BEHAVIORAL SCAI (Spiritual Care Assessment and Intervention)

Study Locations (1)

Indiana

  • Indiana University Melvin & Bren Simon Cancer Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-12-10
Est. Completion 2019-08-28
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT03823313

The ClinicalTrials.gov registry entry for NCT03823313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (83% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Advanced Cancer appearing as the primary indexed condition, and to 1 intervention - of which SCAI (Spiritual Care Assessment and Intervention) is the first listed.

NCT03823313 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03823313 about?

NCT03823313 is a clinical study titled "Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention". The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers. This intervention will assess 4 areas of spiritual experience: meaning and purpose, relationships, transcendence and peace, self-worth and identity. Participants will be asked to ...

What is the current status of trial NCT03823313?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-12-10. Estimated completion is 2019-08-28.

What conditions does trial NCT03823313 study?

This clinical trial studies the following conditions: Advanced Cancer, Metastatic Cancer.

What interventions are being tested in trial NCT03823313?

The interventions under investigation include: SCAI (Spiritual Care Assessment and Intervention) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03823313?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03823313 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.